697305-72-9

Basic information

• Product Name: 4-chloro-3-((dimethylamino)methyl)aniline
• CAS NO: 697305-72-9
• Molecular Weight: 184.669
• Mol File: 697305-72-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-chloro-3-((dimethylamino)methyl)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-3-((dimethylamino)methyl)aniline(697305-72-9)
• EPA Substance Registry System: 4-chloro-3-((dimethylamino)methyl)aniline(697305-72-9)

Safety Data

• Hazardous Substances Data: 697305-72-9(Hazardous Substances Data)

Upstream product

• 6361-21-3 2-chloro-5-nitrobenzaldehyde 
• 697305-62-7 1-(2-chloro-5-nitrophenyl)-N,N-dimethylmethanamine 

Relevant articles and documents

THIENO[3,2-D]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES

Provided are a thieno[3,2-d]pyrimidine derivative of formula (I) or a pharmaceutically acceptable salt thereof having inhibitory activity for protein kinase, and a pharmaceutical composition comprising same for prevention and treatment of abnormal cell growth diseases.

ORGANIC COMPOUNDS

The present invention relates to quinazolinone compounds of the formula wherein R2, R3, R5, R6 R7 and R8 are as defined in the specification and in the claims, in free form or in salt form , processes for their preparation and their use as pharmaceuticals, particularly in the treatment of disorders ameliorated by administration of TRPV1 antagonists.

AMINE COMPOUNDS

The present invention provide a compound of the formula:wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrogen atom, etc.; R4 and R5 are the same or different and each represents a hydrogen, etc.; R6 represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.